Biomarkers of Diabetes
Biomarkers are molecular markers used as direct or indirect markers of the extent of a disease. HbA1c is considered as the biomarker in diabetes for assessing the risk factor related to retinopathy, nephropathy and other vascular diseases. Biomarkers enable preventive measures to be applied at the subclinical stage and the responses to preventive or therapeutic measures to be monitored.
- Novel Biomarkers
- Advances in Molecular Diagnostics
- HbA1c Biomarker
Related Conference of Biomarkers of Diabetes
September 23-24, 2026
24th Global Conference on Diabetes, Endocrinology and Primary Healthcare
Paris, France
September 28-29, 2026
25th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders
Berlin, Germany
November 23-24, 2026
35th International Conference on Clinical Diabetes, Diabetic Medication & Treatment
Amsterdam, Netherlands